Home

Articles from STERIS plc

STERIS Announces Financial Results for Fiscal 2025 Third Quarter
DUBLIN, IRELAND, Feb. 05, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 third quarter ended December 31, 2024. Total revenue from continuing operations for the third quarter of fiscal 2025 increased 6% to $1.4 billion compared with $1.3 billion in the third quarter of fiscal 2024. Constant currency organic revenue from continuing operations for the third quarter also increased 6%.
By STERIS plc · Via GlobeNewswire · February 5, 2025
STERIS Declares Dividend of $0.57 per share
DUBLIN, IRELAND, Jan. 28, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on March 21, 2025, to shareholders of record at the close of business on February 20, 2025.  
By STERIS plc · Via GlobeNewswire · January 28, 2025
STERIS to Host a Conference Call for Fiscal 2025 Third Quarter Financial Results on February 6, 2025
DUBLIN, IRELAND , Jan. 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 third quarter financial results at 9:00 a.m. ET on February 6, 2025. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.
By STERIS plc · Via GlobeNewswire · January 22, 2025
STERIS Announces Outcome of Ethylene Oxide Trial
DUBLIN, IRELAND, Jan. 21, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced that a jury trial that had been ongoing since December 4, 2024, against Isomedix Operations, Inc. (“Isomedix”), a subsidiary of the Company, ended in a mistrial on January 17, 2025.
By STERIS plc · Via GlobeNewswire · January 21, 2025
STERIS Announces Financial Results for Fiscal 2025 Second Quarter
DUBLIN, IRELAND, Nov. 06, 2024 (GLOBE NEWSWIRE) --  - STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 second quarter ended September 30, 2024. Total revenue from continuing operations for the second quarter of fiscal 2025 increased 7% to $1.3 billion compared with $1.2 billion in the second quarter of fiscal 2024. Constant currency organic revenue from continuing operations for the second quarter increased 7%.
By STERIS plc · Via GlobeNewswire · November 6, 2024
STERIS Declares Dividend of $0.57 per share
DUBLIN, IRELAND, Oct. 30, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on December 19, 2024, to shareholders of record at the close of business on November 19, 2024.  
By STERIS plc · Via GlobeNewswire · October 30, 2024
STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financial Results on November 7, 2024
DUBLIN, IRELAND, Oct. 23, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 second quarter financial results at 9:00 a.m. ET on November 7, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.  
By STERIS plc · Via GlobeNewswire · October 23, 2024
STERIS to Present at the Morgan Stanley Healthcare Conference
DUBLIN, IRELAND, Aug. 26, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Wednesday, September 4, 2024. Dan Carestio, President and CEO of STERIS will present at 1:50 p.m. Eastern Time.
By STERIS plc · Via GlobeNewswire · August 26, 2024
STERIS Announces Financial Results for Fiscal 2025 First Quarter
DUBLIN, IRELAND , Aug. 06, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 first quarter ended June 30, 2024. Total revenue from continuing operations for the first quarter of fiscal 2025 increased 8% to $1.3 billion compared with $1.2 billion in the first quarter of fiscal 2024. Constant currency organic revenue from continuing operations for the first quarter increased 6%.
By STERIS plc · Via GlobeNewswire · August 6, 2024
STERIS Raises Dividend to $0.57 per share
DUBLIN, IRELAND, July 31, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. This represents a $0.05 increase in the dividend and the Company’s 19th consecutive year of dividend growth. The dividend is payable on September 20, 2024, to shareholders of record at the close of business on September 5, 2024.  
By STERIS plc · Via GlobeNewswire · July 31, 2024
STERIS to Host a Conference Call for Fiscal 2025 First Quarter Financial Results on August 7, 2024
DUBLIN, IRELAND, July 23, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 first quarter financial results at 9:00 a.m. ET on August 7, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.  
By STERIS plc · Via GlobeNewswire · July 23, 2024
STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year
DUBLIN, IRELAND , May 08, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 fourth quarter ended March 31, 2024. Total revenue for the fourth quarter of fiscal 2024 increased 10% to $1.5 billion compared with $1.4 billion in the fourth quarter of fiscal 2023. Constant currency organic revenue from continuing operations for the fourth quarter increased 7% to $1.4 billion compared with $1.3 billion in the fourth quarter of fiscal 2023.
By STERIS plc · Via GlobeNewswire · May 8, 2024
STERIS Announces Dividend of $0.52 per share
DUBLIN, IRELAND, May 01, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on June 26, 2024, to shareholders of record at the close of business on June 12, 2024.
By STERIS plc · Via GlobeNewswire · May 1, 2024
STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024
DUBLIN, IRELAND, April 24, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 fourth quarter and full year financial results at 9:00 a.m. ET on May 9, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.  
By STERIS plc · Via GlobeNewswire · April 24, 2024
STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital
DUBLIN, IRELAND, April 11, 2024 (GLOBE NEWSWIRE) -- ) - STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced that the Company has entered into a definitive agreement to divest its Dental segment to Peak Rock Capital, a leading middle-market private investment firm, for $787.5 million (the “Transaction”). The Transaction is structured as an equity sale. The Transaction terms also include the opportunity for STERIS to receive an additional earnout of up to $12.5 million, subject to the achievement of certain revenue targets of the Dental segment in fiscal 2025. The Dental segment reported revenue of $407 million and contributed segment operating income of $86 million in the trailing twelve-month period ended December 31, 2023.
By STERIS plc · Via GlobeNewswire · April 11, 2024
STERIS Announces Financial Results for Fiscal 2024 Third Quarter
DUBLIN, IRELAND, Feb. 07, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 third quarter ended December 31, 2023. Revenue as reported for the quarter increased 15% to $1.40 billion compared with $1.22 billion in the third quarter of fiscal 2023. Constant currency organic revenue (see Non-GAAP Financial Measures) increased 10% for the third quarter of fiscal 2024 as compared to the third quarter of fiscal 2023.  
By STERIS plc · Via GlobeNewswire · February 7, 2024
STERIS Announces Dividend of $0.52 per share
DUBLIN, IRELAND , Jan. 30, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on March 22, 2024, to shareholders of record at the close of business on February 23, 2024.
By STERIS plc · Via GlobeNewswire · January 30, 2024
STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024
DUBLIN, IRELAND, Jan. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 third quarter financial results at 9:00 a.m. ET on February 8, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.  
By STERIS plc · Via GlobeNewswire · January 23, 2024
STERIS Announces Financial Results for Fiscal 2024 Second Quarter
DUBLIN, IRELAND, Nov. 07, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 second quarter ended September 30, 2023. Revenue as reported for the quarter increased 12% to $1.34 billion compared with $1.20 billion in the second quarter of fiscal 2023. Constant currency organic revenue (see Non-GAAP Financial Measures) increased 8% for the second quarter of fiscal 2024 as compared to the second quarter of fiscal 2023.  
By STERIS plc · Via GlobeNewswire · November 7, 2023
STERIS Announces Dividend of $0.52 per share
DUBLIN, IRELAND, Oct. 31, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on December 21, 2023, to shareholders of record at the close of business on November 21, 2023.  
By STERIS plc · Via GlobeNewswire · October 31, 2023
STERIS to Host a Conference Call for Fiscal 2024 Second Quarter Financial Results on November 8, 2023
DUBLIN, IRELAND, Oct. 24, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 second quarter financial results at 9:00 a.m. ET on November 8, 2023. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.  
By STERIS plc · Via GlobeNewswire · October 24, 2023
STERIS to Present at the Morgan Stanley Healthcare Conference
DUBLIN, IRELAND , Aug. 30, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) ("STERIS" or the "Company") announced that it will participate in the Morgan Stanley Healthcare Conference in New York City on Wednesday, September 13, 2023.   Dan Carestio, President and CEO of STERIS will present at 8:10 a.m. Eastern Time.
By STERIS plc · Via GlobeNewswire · August 30, 2023
STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD
DUBLIN, IRELAND, Aug. 02, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of the surgical instrumentation, laparoscopic instrumentation and sterilization container assets from BD (Becton, Dickinson and Company) NYSE:BDXNYSEBDX)
By STERIS plc · Via GlobeNewswire · August 2, 2023
STERIS Announces Financial Results for Fiscal 2024 First Quarter
DUBLIN, IRELAND, Aug. 01, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 first quarter ended June 30, 2023. Revenue as reported for the quarter increased 11% to $1.28 billion compared with $1.16 billion in the first quarter of fiscal 2023. Constant currency organic revenue (see Non-GAAP Financial Measures) also increased 11% for the first quarter of fiscal 2024 as compared to the first quarter of fiscal 2023.  
By STERIS plc · Via GlobeNewswire · August 1, 2023
STERIS Raises Dividend to $0.52 per share
DUBLIN, IRELAND , July 26, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. This represents a $0.05 increase in the dividend and the Company’s 18th consecutive year of dividend growth. The dividend is payable on September 22, 2023, to shareholders of record at the close of business on September 6, 2023.  
By STERIS plc · Via GlobeNewswire · July 26, 2023
STERIS to Host a Conference Call for Fiscal 2024 First Quarter Financial Results on August 2, 2023
DUBLIN, IRELAND, July 19, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 first quarter financial results at 9:00 a.m. ET on August 2, 2023. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.  
By STERIS plc · Via GlobeNewswire · July 19, 2023
STERIS Expands Healthcare Products Offering with Acquisition of Surgical Instrumentation Assets from Becton, Dickinson and Company for $540 million
DUBLIN, IRELAND , June 20, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced that the Company has signed a definitive agreement to purchase the surgical instrumentation, laparoscopic instrumentation and sterilization container assets from Becton, Dickinson and Company NYSE:BDXNYSEBDX)
By STERIS plc · Via GlobeNewswire · June 20, 2023
STERIS Announces Financial Results for Fiscal 2023 Fourth Quarter and Full Year
DUBLIN, IRELAND , May 10, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 fourth quarter and full year ended March 31, 2023. Revenue as reported for the quarter increased 14% to $1.38 billion compared with $1.21 billion in the fourth quarter of fiscal 2022. Constant currency organic revenue (see Non-GAAP Financial Measures) increased 16% for the fourth quarter of fiscal 2023 as compared to the fourth quarter of fiscal 2022.  
By STERIS plc · Via GlobeNewswire · May 10, 2023
STERIS Announces $500 million Share Repurchase Authorization and Declares $0.47 per share Dividend
DUBLIN, IRELAND, May 03, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that STERIS's Board of Directors has authorized a new share buyback program for the purchase of up to $500 million of the Company's ordinary shares. Shares may be repurchased from time to time through open market transactions, including 10b5-1 plans. The repurchase program may be suspended or discontinued at any time.
By STERIS plc · Via GlobeNewswire · May 3, 2023
STERIS Appoints Esther M. Alegria, Ph.D. to Board of Directors
DUBLIN, IRELAND, May 03, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that Esther M. Alegria, Ph.D. has been elected to the Board of Directors, effective today.
By STERIS plc · Via GlobeNewswire · May 3, 2023
STERIS to Host a Conference Call for Fiscal 2023 Fourth Quarter and Full Year Financial Results on May 11, 2023
DUBLIN, IRELAND, April 24, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 fourth quarter and full year financial results at 9:00 a.m. ET on May 11, 2023. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.  
By STERIS plc · Via GlobeNewswire · April 24, 2023
STERIS Announces Financial Results for Fiscal 2023 Third Quarter
DUBLIN, IRELAND, Feb. 08, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 third quarter ended December 31, 2022. Revenue as reported for the quarter increased 1% to $1.22 billion compared with $1.21 billion in the third quarter of fiscal 2022. Constant currency organic revenue (see Non-GAAP Financial Measures) increased 7% for the third quarter of fiscal 2023 as compared to the third quarter of fiscal 2022.  
By STERIS plc · Via GlobeNewswire · February 8, 2023
STERIS Declares $0.47 per share Dividend
DUBLIN, IRELAND, Feb. 01, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.47 per share. The dividend is payable March 23, 2023 to shareholders of record at the close of business on February 24, 2023.  
By STERIS plc · Via GlobeNewswire · February 1, 2023
STERIS to Host a Conference Call for Fiscal 2023 Third Quarter Financial Results on February 9, 2023
DUBLIN, IRELAND, Jan. 25, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 third quarter financial results at 10:00 a.m. ET on February 9, 2023. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.  
By STERIS plc · Via GlobeNewswire · January 25, 2023
STERIS Announces Financial Results for Fiscal 2023 Second Quarter
By STERIS plc · Via GlobeNewswire · November 9, 2022
STERIS Declares $0.47 per share Dividend
DUBLIN, IRELAND, Nov. 02, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.47 per share. The dividend is payable December 16, 2022 to shareholders of record at the close of business on November 22, 2022.  
By STERIS plc · Via GlobeNewswire · November 2, 2022
STERIS to Host a Conference Call for Fiscal 2023 Second Quarter Financial Results on November 10, 2022
DUBLIN, IRELAND, Oct. 25, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 second quarter financial results at 10:00 a.m. ET on November 10, 2022. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.  
By STERIS plc · Via GlobeNewswire · October 25, 2022